Hi Friederike,
These gene-specific copy-number calls have always been very tricky, and they are almost impossible to get right 100% of the time using fully automated methods.
Just to make sure we are all on the same page, here are a couple of basic facts about the CNAs in TCGA samples in cBioPortal:
- copy-number in TCGA is derived from Affymetrix SNP 6 arrays using the GISTIC 2 algorithm
- by default, cBioPortal only shows high level amplifications and deep deletions in OncoPrints. You can use OQL to show the other events. However, the patient view only shows deep deletions and amplifications
- for calling shallow deletions, GISTIC uses the same threshold across all samples
- for calling deep deletions, GISTIC uses a sample-specific threshold in an attempt to correct for purity
- GISTIC does not correct for ploidy, meaning that whole genome duplicated samples are very tricky to get right (one of the main reasons we use shallow vs deep as opposed to heterozygous vs homozygous)
- sub clonal deep deletions would probably be called shallow deletions
- partial deep deletions of a gene are also called deep deletions - in these cases, you can observe a mutation even in a gene that is called deleted
- it is also possible that a gene is incorrectly called “deep deletion”, and that’s why you observe a mutation in that same sample
- I don’t think GISTIC treats the X chromosome any different, but I agree with you that different rules should be used here, especially in men
So to answer your specific question, there are a couple of different explanations for heterozygous losses in X chromosome genes in men:
- the deletion is sub-clonal
- the tumor is whole-genome duplicated, and only one of two copies are lost
- the algorithm made an incorrect call
Does this make sense?
I would suggest to inspect the segmented copy-number data more closely in IGV to get a better sense of what happens to your gene of interest in your specific cancer type.
I hope this helps.
Niki.
Hi Sjoerd and Nikolaus,
I wanted to follow up on the question of deep deletions vs shallow deletions in male patients on the sex chromosomes. You already mentioned the possibility that in parts of the tumor complete deletion took place.
I am still not entirely sure what it then means that male patients for a gene on the X chromosome can show shallow AND deep deletions, especially since you mentioned that even in patients with deep deletions, mutations can be found. Could you possibly elaborate?
Best regards,